Quanterix Corporation

    Jurisdiction
    United States
    ISIN
    US74766Q1013 (QTRX)
    Sectors
    1. Healthcare
    2. Medical - Devices

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    4 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    5 / 7

    Profile

    Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €107.58M
    Gross margin
    55.5%
    EBIT
    -€77.21M
    EBIT margin
    -71.8%
    Net income
    -€60.49M
    Net margin
    -56.2%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €155.73M +44.8% -€44.38M -26.6%
    €175.86M +12.9% -€34.70M -21.8%
    €196.41M +11.7% -€34.38M -0.9%

    Dividends

    No dividend payouts

    Earnings Calls

    Latest earnings call: May 8, 2024

    Investor transactions

    Name Shares Value Last change Change type
    James Anderson 601K $3.91M -29K Sell
    Peter Brown 203K $1.32M +144K Buy

    Add to watchlist

    Notifications